Dr. Donald Alcendor

Dr. Alcendor completed his post-graduate studies at the NIH and Johns Hopkins University, in Baltimore Maryland in departments of Molecular Virology and Viral Oncology respectively. Dr. Alcendor was also a research consultant to the Viral Vector Core Laboratory in Viral Oncology, at Johns Hopkins, and a Simian Cytomegalovirus Expert for the FDA, Division of Vaccine Injury and Compensation Program for the Department of Health and Human Services in Rockville, Maryland. He is a mentor for the FDA Office of Minority Health, Health Disparities Fellowship. He has also selected as a Minority Scholar in Cancer Research by the American Association for Cancer Research (AACR). He received the Nashville Business Journal Health Care Hero Award in Research. He is also a committee member on the independent Research Evaluation and Decision Panel (REDP) for the AIDS Cancer and Specimen Resource of the NCI-AIDS Malignancy Program. He is a Brain-on-chip investigator in partnership with Vanderbilt and the Cleveland Clinic. He was recently funded to develop the Blood-Retinal-Barrier on a Chip with implications for cancer research. He is a Research Liaison for FDA Office of Minority Health MOU with Meharry Medical College. He is a consultant and voting member on the FDA Antiviral Drug Advisory Committee. Dr. Alcendor research interest involves KSHV Regulation of Fibulins in Kaposi’s sarcoma: Implications for the Role of Extracellular Matrix Proteins in Tumorigenesis (AIDS related malignancy); and Models for Cytomegalovirus Induced Congenital Disease and its impact on the blood-brain and retinal barriers.